Literature DB >> 12956819

Suicide, suicidality and suicide prevention in affective disorders.

H J Möller1.   

Abstract

OBJECTIVE: It is well known that functional psychiatric disorders are one of the main causes of suicidal behaviour. This paper discusses the epidemiology and risk factors of suicidal behaviour in affective disorders and goes on to describe the treatment and prevention of such suicidal behaviour.
METHOD: A narrative overview of relevant epidemiological and drug studies.
RESULTS: About 60-70% of patients with acute depression experience suicidal ideas. There is a high incidence of suicide (10-15%) in depressive patients. Psychopharmacological treatment with antidepressants and/or mood stabilizers is the most successful approach to avoid the risk of suicidal behaviour. In addition, psychotherapeutic and psychosocial interventions are of importance.
CONCLUSION: Suicidal behaviour and suicide must be considered when treating patients with affective disorders. The complex causation of suicidality has to be borne in mind when considering methods of suicide prevention. In order to obtain the best results, psychosocial, psychotherapeutic and psychopharmacological approaches should be combined, depending on the risk factors of each individual patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956819

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  23 in total

Review 1.  The costs of depression.

Authors:  Ronald C Kessler
Journal:  Psychiatr Clin North Am       Date:  2011-12-16

Review 2.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

3.  Intimate partner violence and suicidal ideation in pregnant women.

Authors:  Jeanne L Alhusen; N Frohman; Genevieve Purcell
Journal:  Arch Womens Ment Health       Date:  2015-03-10       Impact factor: 3.633

Review 4.  Pathogenetic and therapeutic applications of microRNAs in major depressive disorder.

Authors:  Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-14       Impact factor: 5.067

Review 5.  Effectiveness of Psychological and Educational Interventions to Prevent Depression in Primary Care: A Systematic Review and Meta-Analysis.

Authors:  Sonia Conejo-Cerón; Patricia Moreno-Peral; Alberto Rodríguez-Morejón; Emma Motrico; Desirée Navas-Campaña; Alina Rigabert; Carlos Martín-Pérez; Antonina Rodríguez-Bayón; María Isabel Ballesta-Rodríguez; Juan de Dios Luna; Javier García-Campayo; Miquel Roca; Juan Ángel Bellón
Journal:  Ann Fam Med       Date:  2017-05       Impact factor: 5.166

Review 6.  Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

Review 7.  Experimental psychiatric illness and drug abuse models: from human to animal, an overview.

Authors:  Scott Edwards; George F Koob
Journal:  Methods Mol Biol       Date:  2012

8.  Suicidal behavior and alcohol abuse.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Giovanni Dominici; Stefano Ferracuti; Giorgio D Kotzalidis; Giulia Serra; Paolo Girardi; Luigi Janiri; Roberto Tatarelli; Leo Sher; David Lester
Journal:  Int J Environ Res Public Health       Date:  2010-03-29       Impact factor: 3.390

9.  What Can Influence Iranian Suicide Attempters to Go Through the Process of Non-Fatal Suicide Act Once Again? A Preliminary Report.

Authors:  Gholam Reza Ghassemi Toudehskchuie; Mahsa Fereidoon
Journal:  Community Ment Health J       Date:  2016-03-19

10.  Heterotrimeric g proteins: insights into the neurobiology of mood disorders.

Authors:  Javier González-Maeso; J Javier Meana
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.